Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Low predictive power of clinical features for relapse prediction after antidepressant discontinuation in a naturalistic setting

View through CrossRef
1AbstractBackgroundThe risk of relapse after antidepressant medication (ADM) discontinuation is high. Predictors of relapse could guide clinical decision-making, but are yet to be established.MethodWe assessed demographic and clinical variables in a longitudinal observational study before antidepressant discontinuation. State-dependent variables were re-assessed either after discontinuation or before discontinuation after a waiting period. Relapse was assessed during six months after discontinuation. We applied logistic general linear models in combination with least absolute shrinkage and selection operator and elastic nets to avoid overfitting in order to identify predictors of relapse and estimated their generalisability using cross-validation.ResultsThe final sample included 104 patients (age: 34.86 (11.1), 77% female) and 57 healthy controls (age: 34.12 (10.6), 70% female). 36% of the patients experienced a relapse. Treatment by a general practitioner increased the risk of relapse. Although within-sample statistical analyses suggested reasonable sensitivity and specificity, out-of-sample prediction of relapse was at chance level. Residual symptoms increased with discontinuation, but did not relate to relapse.Conclusion and RelevanceDemographic and standard clinical variables appear to carry little predictive power and therefore are of limited use for patients and clinicians in guiding clinical decision-making.
Title: Low predictive power of clinical features for relapse prediction after antidepressant discontinuation in a naturalistic setting
Description:
1AbstractBackgroundThe risk of relapse after antidepressant medication (ADM) discontinuation is high.
Predictors of relapse could guide clinical decision-making, but are yet to be established.
MethodWe assessed demographic and clinical variables in a longitudinal observational study before antidepressant discontinuation.
State-dependent variables were re-assessed either after discontinuation or before discontinuation after a waiting period.
Relapse was assessed during six months after discontinuation.
We applied logistic general linear models in combination with least absolute shrinkage and selection operator and elastic nets to avoid overfitting in order to identify predictors of relapse and estimated their generalisability using cross-validation.
ResultsThe final sample included 104 patients (age: 34.
86 (11.
1), 77% female) and 57 healthy controls (age: 34.
12 (10.
6), 70% female).
36% of the patients experienced a relapse.
Treatment by a general practitioner increased the risk of relapse.
Although within-sample statistical analyses suggested reasonable sensitivity and specificity, out-of-sample prediction of relapse was at chance level.
Residual symptoms increased with discontinuation, but did not relate to relapse.
Conclusion and RelevanceDemographic and standard clinical variables appear to carry little predictive power and therefore are of limited use for patients and clinicians in guiding clinical decision-making.

Related Results

Amygdala reactivity, antidepressant discontinuation and relapse: a longitudinal, observational study with a randomized component
Amygdala reactivity, antidepressant discontinuation and relapse: a longitudinal, observational study with a randomized component
Importance: Antidepressant discontinuation substantially increases the risk of a depression relapse. The neurobiological mechanisms through which this happens are not known. Amygda...
Delay discounting correlates with depression but does not predict relapse after antidepressant discontinuation
Delay discounting correlates with depression but does not predict relapse after antidepressant discontinuation
Background: Approximately one third of people with major depressive disorder experience a relapse within six months of discontinuing antidepressant medication (ADM), however, relia...
The relationship between resting-state functional connectivity, antidepressant discontinuation and depression relapse
The relationship between resting-state functional connectivity, antidepressant discontinuation and depression relapse
AbstractThe risk of relapsing into depression after stopping antidepressants is high, but no established predictors exist. Resting-state functional magnetic resonance imaging (rsfM...
The relationship between resting-state functional connectivity, antidepressant discontinuation and depression relapse
The relationship between resting-state functional connectivity, antidepressant discontinuation and depression relapse
AbstractThe risk of relapsing into depression after stopping antidepressants is high, but no established predictors exist. Resting-state functional magnetic resonance imaging (rsfM...
Clonal Evolution of Acute Myeloid Leukemia Following Allogeneic Stem Cell Transplantation
Clonal Evolution of Acute Myeloid Leukemia Following Allogeneic Stem Cell Transplantation
Abstract The evolutionary model of cancer progression suggests that malignant clones survive initial therapy and acquire new mutations, ultimately resulting in thera...
Targeting Genomic Heterogeneity of Adult Acute Lymphoblastic Leukemia
Targeting Genomic Heterogeneity of Adult Acute Lymphoblastic Leukemia
Abstract Introduction: In acute lymphoblastic leukemia (ALL) genetic diversity at diagnosis has been reported to be correlated with an increased likelihood of emergi...
A rare case of antidepressant discontinuation syndrome triggered by domperidone: Clinical insights and literature review
A rare case of antidepressant discontinuation syndrome triggered by domperidone: Clinical insights and literature review
Antidepressant discontinuation syndrome is commonly observed among patients who abruptly discontinue or reduce the dosage of an antidepressant that has been administered for at lea...

Back to Top